Identifying individuals suitable for monogenic autoimmunity testing and gene discovery studies is challenging: early-onset type 1 diabetes mellitus can cluster with additional autoimmune diseases due to shared polygenic risk and islet- and other organ-specific autoantibodies are present in both monogenic and polygenic aetiologies. We aimed to assess whether a type 1 diabetes genetic risk score (GRS) could identify monogenic autoimmune diabetes and be useful to prioritise individuals for gene discovery studies
BackgroundAround 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood an...
Type 1 diabetes (T1D) is a chronic disease of high blood glucose caused by autoimmune destruction of...
Background: Around 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood ...
Identifying individuals suitable for monogenic autoimmunity testing and gene discovery studies is ch...
Distinguishing patients with monogenic diabetes from Type 1 diabetes (T1D) is important for correct ...
Distinguishing patients with monogenic diabetes from Type 1 diabetes (T1D) is important for correct ...
Iterative advances in understanding of the genetics of type 1 diabetes have identified >70 genetic r...
Iterative advances in understanding of the genetics of type 1 diabetes have identified >70 genetic r...
Iterative advances in understanding of the genetics of type 1 diabetes have identified >70 genetic r...
Genome-wide association studies have identified 57 genetic risk loci for type 1 diabetes. Progress h...
Genome-wide association studies have identified 57 genetic risk loci for type 1 diabetes. Progress h...
Genome-wide association studies have identified 57 genetic risk loci for type 1 diabetes. Progress h...
Published onlineThis is the author accepted manuscript. The final version is available from the publ...
BackgroundAround 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood an...
BackgroundAround 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood an...
BackgroundAround 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood an...
Type 1 diabetes (T1D) is a chronic disease of high blood glucose caused by autoimmune destruction of...
Background: Around 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood ...
Identifying individuals suitable for monogenic autoimmunity testing and gene discovery studies is ch...
Distinguishing patients with monogenic diabetes from Type 1 diabetes (T1D) is important for correct ...
Distinguishing patients with monogenic diabetes from Type 1 diabetes (T1D) is important for correct ...
Iterative advances in understanding of the genetics of type 1 diabetes have identified >70 genetic r...
Iterative advances in understanding of the genetics of type 1 diabetes have identified >70 genetic r...
Iterative advances in understanding of the genetics of type 1 diabetes have identified >70 genetic r...
Genome-wide association studies have identified 57 genetic risk loci for type 1 diabetes. Progress h...
Genome-wide association studies have identified 57 genetic risk loci for type 1 diabetes. Progress h...
Genome-wide association studies have identified 57 genetic risk loci for type 1 diabetes. Progress h...
Published onlineThis is the author accepted manuscript. The final version is available from the publ...
BackgroundAround 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood an...
BackgroundAround 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood an...
BackgroundAround 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood an...
Type 1 diabetes (T1D) is a chronic disease of high blood glucose caused by autoimmune destruction of...
Background: Around 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood ...